Your browser doesn't support javascript.
loading
Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett's oesophagus during routine clinical care.
Tokuyama, Minami; Geisler, Daniel; Deitrick, Christopher; Fasanella, Kenneth E; Chennat, Jennifer S; McGrath, Kevin M; Pai, Reetesh K; Davison, Jon M.
  • Tokuyama M; The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Geisler D; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Deitrick C; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Fasanella KE; Department of Medicine, Division of Gastroenterology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Chennat JS; Department of Medicine, Division of Gastroenterology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • McGrath KM; Department of Medicine, Division of Gastroenterology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Pai RK; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Davison JM; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Histopathology ; 77(3): 481-491, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32431062

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Esófago de Barrett / Biomarcadores de Tumor / Proteína p53 Supresora de Tumor Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lesiones Precancerosas / Esófago de Barrett / Biomarcadores de Tumor / Proteína p53 Supresora de Tumor Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article